Targeting dendritic cells to treat multiple sclerosis

被引:0
|
作者
Manuel Comabella
Xavier Montalban
Christian Münz
Jan D. Lünemann
机构
[1] Multiple Sclerosis Center of Catalonia,
[2] Vall d'Hebron University Hospital,undefined
[3] Institute of Experimental Immunology,undefined
[4] University Hospital of Zürich,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Dendritic cells are specialized antigen-presenting cells that are necessary for inducing immunity and regulating immune tolerance. Understanding how these cells regulate adaptive immune responses has aided the development of a number of novel immunotherapies. In this article, Comabella and colleagues provide an overview of dendritic cell function and evaluate the potential of these therapies to treat multiple sclerosis.
引用
收藏
页码:499 / 507
页数:8
相关论文
共 50 条
  • [31] To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis
    De laere, Maxime
    Berneman, Zwi N.
    Cools, Nathalie
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (03): : 178 - 192
  • [32] Immunophenotype of Myeloid and Plasmacytoid Dendritic Cells in Patients with Multiple Sclerosis
    Hancharou, A. Y.
    Titov, L. P.
    Ramanava, I. U.
    DuBuske, L. M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB228 - AB228
  • [33] Myeloid dendritic cells are activated in secondary progressive multiple sclerosis
    Karni, A
    Khoury, SJ
    Cai, GF
    Freeman, G
    Hafler, D
    Weiner, HL
    [J]. NEUROLOGY, 2002, 58 (07) : A326 - A327
  • [34] Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
    Xie, Zhong-Xiang
    Zhang, Hong-Liang
    Wu, Xiu-Juan
    Zhu, Jie
    Ma, Di-Hui
    Jin, Tao
    [J]. MEDIATORS OF INFLAMMATION, 2015, 2015
  • [35] Multiple sclerosis: impaired phenotype and maturation of plasmacytoid dendritic cells
    Stasiolek, M
    Bayas, A
    Kruse, N
    Toyka, KV
    Gold, R
    Selmaj, K
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 158 - 158
  • [36] Dendritic cells are activated in secondary progressive multiple sclerosis.
    Karni, A
    Abraham, M
    Cai, GF
    Freeman, G
    Hafler, D
    Khoury, S
    Weiner, H
    [J]. CLINICAL IMMUNOLOGY, 2002, 103 (03) : S118 - S119
  • [37] Targeting dendritic cells
    Slifka, M
    [J]. TRENDS IN MICROBIOLOGY, 2001, 9 (01) : 11 - 11
  • [38] Targeting dendritic cells
    Johnson, SA
    Takashima, A
    Zheng, WJ
    Edelbaum, D
    Timares, L
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 60 - 60
  • [39] To treat or not to treat the person with clinical multiple sclerosis – a dilemma
    A. D. Sadovnick
    [J]. Neurological Sciences, 2001, 22 : 205 - 207
  • [40] To treat or not to treat the person with clinical multiple sclerosis - a dilemma
    Sadovnick, AD
    [J]. NEUROLOGICAL SCIENCES, 2001, 22 (02) : 205 - 207